Explorer les evidences

6,1 %Post-intervention, risk factor knowledge improved from 6.1% to 59.5% in the intervention group.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 12 observations

Knowledge about 'General Awareness', 'HPV Vaccinations', 'Risk Factors', and 'Symptoms' increased between Phases 2 and 1.

Nigeriacancer du col de l'utéruspublié 2022BMC public healthPubMeddocument de 13 observations

Cervical cancer is the second most common cancer in low- to middle-income countries.

Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 7 observations

Knowledge of cervical cancer risk factors, causes, and prevention strategies was poor among women of reproductive age in Ibadan.

Nigeriacancer du col de l'utéruspublié 2020JCO global oncologyPubMeddocument de 2 observations

76,2 %Cervical cancer awareness was high (76.2%) among women of reproductive age living with HIV in North Central Nigeria.

Nigeriacancer du col de l'utéruspublié 2025The Pan African medical journalPubMeddocument de 4 observations

36,7 %36.7% of rural women in North Central Nigeria cited mass media as a source of information on cervical cancer.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

99 %HPV infection has been detected in more than 99% of cervical cancers throughout the world.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2024West African journal of medicinePubMeddocument de 4 observations

80 %Routine cervical cancer screening and early treatment can prevent up to 80% of cervical cancers.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 13 observations

7,2 %Among female undergraduates in a tertiary institution in south eastern Nigeria, 7.2% have been previously screened for cervical cancer.

Nigeriacancer du col de l'utéruspublié 2021Journal of preventive medicine and hygienePubMeddocument de 11 observations

23,4 %23.4% of the 231 women had basic information on the treatment of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations

81,5 %Among women with invasive cervical cancer (ICC), 81.5% were positive for high-risk HPV.

Nigeriacancer du col de l'utérus · high-risk human papillomavirusobservé 2020–2022publié 2023BMC cancerPubMeddocument de 14 observations

29,7 %After the intervention, cervical cancer screening participation was 29.7%.

Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 7 observations

1 per_101 in every 10 women in a rural community in Enugu State, Nigeria, knew that HPV vaccination prevents against cervical cancer.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 8 observations

47 %Programmed death ligand-1 was positive in 47% of the cervical carcinoma cases.

Nigeriacancer du col de l'utérusobservé 2012–2016publié 2024The Pan African medical journalPubMeddocument de 5 observations

99,4 %99.4% of women in urban slums of Lagos, Nigeria did not know the symptoms of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 13 observations

The majority of the countries with the highest cervical cancer burden are in sub-Saharan Africa, including Nigeria.

Nigeriacancer du col de l'utéruspublié 2024The Pan African medical journalPubMeddocument de 8 observations

0,5 fractionFor half of the 'Pap Smears' assessment items, knowledge gained at Phase-2 became negative (reversed) at Phase-4.

Nigeriacancer du col de l'utéruspublié 2022BMC public healthPubMeddocument de 13 observations

6 043 women6,043 women living with HIV were screened for cervical cancer in Nigeria.

Nigeriacancer du col de l'utérusAfrica CDCdocument de 52 observations

5 %Cervical cancer screening prevalence among women aged 30–49 years in Nigeria was 5% (95% CI = 4.6, 5.5) according to the 2023–24 Nigeria Demographic and Health Survey.

Nigeriacancer du col de l'utérusobservé 2023–24PubMeddocument de 3 observations

4 %Only 4.0% of the female postgraduate students at the University of Ibadan had been screened for cervical cancer at the time of the study.

Nigeriacancer du col de l'utéruspublié 2024BMC women's healthPubMeddocument de 6 observations

22,9 %22.9% of the 231 women agreed that cervical cancer screening is only meant for older women aged 30–45 years.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations

60,5 %60.5% of the participants knew the causes of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 7 observations

51,2 %268 (51.2%) of the 514 surveyed women had poor knowledge of cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2023African journal of reproductive healthPubMeddocument de 4 observations

49,7 %Chemotherapy was the major therapy option received by 49.7% of the cervical cancer patients.

Nigeriacancer du col de l'utéruspublié 2023African health sciencesPubMed

29,4 %29.4% of the 231 women cited expensive cost of screening as a reason for avoiding it.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations